Evoke plc (LON:EVOK - Get Free Report) traded down 18.7% on Wednesday . The company traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares changed hands during mid-day trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on EVOK shares. Jefferies Financial Group reiterated a "buy" rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank dropped their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating on the stock in a research note on Wednesday, December 4th.
View Our Latest Stock Analysis on Evoke
Evoke Trading Down 1.1 %
The business has a 50 day simple moving average of GBX 68.88 and a two-hundred day simple moving average of GBX 63.49. The stock has a market cap of £224.78 million, a price-to-earnings ratio of -1.26 and a beta of 0.84.
Evoke (LON:EVOK - Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Research analysts anticipate that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,189.04). 27.00% of the stock is currently owned by company insiders.
About Evoke
(
Get Free Report)
Featured Stories
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.